21 April 2023
Counterfeit BIO-GEN CORTICAL BONE substitutes from Bioteck S.p.A.
The Italian medical device authority has informed Swissmedic of the discovery of counterfeit BIO-GEN CORTICAL BONE bone substitutes from Bioteck S.p.A. used in dentistry. The components of these counterfeit products are not yet known and health risks cannot be excluded. They should not be used under any circumstances.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Revision of the Guidance document Authorisation Biosimilar